NFKB1 and cancer: The ephrin type‐A receptor 4 (EPHA4) protein on the surface of TAMs is upregulated during EMT and binds directly to the receptor on cancer cells, which activates the NF‐kB pathway in cancer cells to facilitate the maintenance of homeostasis in the CSCs.10